Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-05

Clinical Trial Update: A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 study comparing GT267-004 to vancomycin and to metronidazole in patients with Clostridioides difficile infection (C. difficile-associated diarrhea). The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GT267-004
  • METRONIDAZOLE (Metronidazole)
  • Vancomycin (vancomycin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Clostridium Enterocolitis, Pseudomembranous Colitis | Phase 3 | Status: COMPLETED